1. [1] Brasseur, O., Ronald, A. and Piot, P. (1996) STD drugs. In: Control of Sexually Transmitted Diseases (Dallabetta, G.A., Laga, M. and Lamptey, P.R., Eds.), pp. 129â148. AIDSCAP/Family Health International, VA.
2. [2] Erbelding, E. and Quinn, T.C. (1997) The impact of antimicrobial resistance on the treatment of sexually transmitted diseases. In: Infectious Disease Clinics of North America-Antimicrobial Resistance (Tenover, F.C. and McGowan, J.E., Eds.), pp. 889â903. WB Saunders, Philadelphia, PA.
3. Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy;Fekete;Clin. Microbiol. Rev.,1993
4. [4] National Committee for Clinical Laboratory Standards (1998) Performance Standards for Antimicrobial Susceptibility Testing; Eighth Informational Supplement M100-S8, Vol. 8, No.1, pp. 26, 27, 66, 67. NCCLS, PA.
5. Antimicrobial resistance in Neisseria gonorrhoeae;Lind;Clin. Infect. Dis.,1997